Method for producing 8-methylnonanoic acid by microorganisms
By genetically modifying the E. coli strain to express specific genes and using the isobutyryl-CoA pathway, the problems of high production costs and environmental impact of 8-methylnonanoic acid are solved, and efficient and sustainable microbial fermentation technology is achieved, providing high yields 8-methylnonanoic acid production in high purity.
Patent Information
- Application Number
- CN201780079774.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2016-12-22
- Filing Date
- 2017-12-22
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2037-12-22
AI Technical Summary
The prior art is difficult to efficiently and economically produce 8-methylnonolic acid (8M), an intermediate for capsaicin biosynthesis, and has problems with energy-intensive solvent use, environmental impact and high cost based on plant extraction methods. .
By genetically modifying the E. coli strain, expressing the KASIIIa, KASIIIb, FatB and FatB2 genes, using isobutyryl-CoA as an intermediate, 8-methylnonoic acid is produced through various pathways (deadline synthesis, ACS or PCT pathways), realizing microbial results Efficient production of fermentation process.
High yield and high purity 8-methylnonanoic acid production is achieved, reducing production costs, reducing the occupation of agricultural land, and providing a sustainable industrial-grade production method.
Smart Images

Figure CN110291194B_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This patent application claims priority to U.S. Provisional Patent Application No. 62 / 437,792, filed December 22, 2016, the contents of which are incorporated herein by reference in their entirety. Technical Field
[0003] The field of the present invention relates to methods and processes that can be used for the microbial production of 8-methylnonanoic acid (CAS No. 5963-14-4) (hereinafter referred to as "8M"), the direct precursor of capsaicin. Importantly, the present disclosure provides methods for producing 8M at yields that are not possible in plant-based systems and the sequence of the FatB2 protein. The present disclosure provides genetically modified Escherichia coli strains that have been modified to biosynthesize 8M, methods for producing genetically modified microorganisms for producing 8M, and production methods for producing 8M in high yields and purity levels starting from specific raw materials. In the present disclosure, KASIIIa, KASIIIb, FatB and FatB2 genes were identified and characterized, including their participation in the biosynthesis of 8M. Background Art
[0004] In some embodiments, the present disclosure relates to methods for modifying microbial strains to produce 8-methylnonanoic acid (also known as "isooctanoic acid," a desired branched, medium-chain fatty acid compound) in high yield using glucose or isobutyric acid as a feed source, depending on the different pathways developed for isobutyryl-CoA formation in microbial production strains. Capsaicinoid compounds (including but not limited to capsaicin (CP), dihydrocapsaicin (DHCP), novarillidine (NV)) are the "spicy" components of chili peppers and are effective in preventing a variety of conditions by promoting energy metabolism, stimulating the central nervous system, and aiding weight loss via activation of lipolytic enzymes. In addition, these compounds can be used to sterilize the gastrointestinal tract, improve immunity when consumed, and can also effectively activate immunity and reduce fatigue. In the production of capsaicinoids, 8M compounds are necessary intermediates and degradation products of CP ( Figure 1 ).
[0005] Capsaicin Chemistry
[0006] "Pungency" or irritation is a unique characteristic of the peppers in the genus Capsicum, which produces an alkaloid called capsaicin. In nature, it is believed that capsaicin is present in plants to prevent mammals from eating its fruit and destroying seeds. Humans can perceive capsaicin via receptors structurally related to members of transient receptor potential channels (or "TRP" families of ion channels). Similar to other important receptors in sensory neurons, the capsaicin receptor ("TRPV1" is also referred to as vanillic acid TRP, vanillic acid 1 receptor or TRPV1) regulates the pungent smell and pain / heat sensation associated with capsaicin and piperine by reversibly losing sensitivity to capsaicin and other pain and heat stimuli when it is in the long-term exposure to the same stimulus (Caterina et al., 1997). This phenomenon can partially explain why humans can tolerate and even enjoy spicy food, because pain sensors may be turned off after long-term exposure.
[0007] Capsaicin (CP), 8-methyl-N-vanillin-trans-6-nonenamide, and dihydrocapsaicin (DHCP), 8-methyl-N-vanillin-nonenamide, are two major capsaicinoids commonly found together in plants and responsible for up to 90% of the pungency of the pepper family (Garcés-Claver et al., 2007). With respect to the present disclosure, 8M is the direct biosynthetic precursor of CP, but is generally only available in very small quantities when derived from plant-based materials.
[0008] Generally, the capsaicin content of red peppers ranges from 0.1% w / w to 1% w / w (Govindarajan and Sathyanarayana 1991), and for many uses, methods for concentrating CP and / or DHCP compounds are needed for any industrial or commercial use. As for 8M, it significantly increases the yield of capsaicin when added to fixed and free-suspended cells of C. frutescens, but is almost impossible to extract in appreciable quantities from plant-based sources.
[0009] In addition to its main use as an ingredient or trace additive in food, capsaicin also has many pharmaceutical uses and medical uses. It has been found that it plays a series of physiological and pharmacological effects, including analgesia, anticancer, anti-inflammatory, antioxidant and anti-obesity activity, and is used as the main component of ointments, patches, oils and creams, which are designed to alleviate the pain caused by various diseases (such as vasomotor rhinitis, osteoarthritis and rheumatoid arthritis) (Aza-González et al., 2011). Capsaicin is currently used as the main active ingredient of self-protection aerosol sprays on the market (Reilly et al., 2001, commonly known as "anti-wolf spray"). In addition, according to current reports, capsaicin consumption reduces plasma cholesterol and improves endothelial function in hamsters (Liang et al., 2013). Due to these diverse and growing uses of capsaicin in food, medicine and defense, including 8M, the international market demand for capsaicin and capsaicin is gradually increasing.
[0010] The genus Capsicum includes more than 20 species of peppers, of which sweet pepper (C. annuum), sharp pepper (C. frutescens), yellow lantern pepper (C. chinense), berry pepper (C. baccatum), and hairy pepper (C. pubescens) have been domesticated (Walsh and Hoot, 2001). Due to the different levels and types of capsaicin present, there is extensive genetic variation in the pungency or pungent level of various pepper species. For example, the non-pungent sweet bell pepper from sweet pepper scores 0.0 SHU (Scoville Heat Unit; a scale indicating the amount of capsaicin), while the "Bhut Jolokia" or devil pepper is a hybrid between yellow lantern pepper and sharp pepper from northern India, which scores up to 1,001,304 SHU (Bosland and Baral, 2007) (see Table 1).
[0011] Table 1 :
[0012]
[0013] In vivo, capsaicin is synthesized by capsaicin synthase (CS / AT3 / Pun1), an acyltransferase that transfers the 8-methylnonanoyl moiety from 8-methylnonanoyl-CoA to vanillinamine to form an amide conjugate ( Figure 1, Chen et al., 2015 and Ogawa et al., 2015). Vanillinamine is formed by the phenylpropionic acid pathway, whereas branched-chain fatty acids are derived from branched-chain amino acids, such as valine (Curry et al., 1999; Stewart et al., 2007; Mazourek et al., 2009). The limitations on the production and use of capsaicinoids mainly stem from the need to extract them from plants. Typically, pure CP extracted from plants is typically rated at approximately 16,000,000 Scoville units on the pungency index and sells for over $5000 USD per gram at this concentration (Batchelor, 2000) (see Table 1). However, the actual capsaicinoid content present in peppers is generally very low and can be greatly affected by environmental and growth conditions, leading to problems of sustainability and consistency. The production of 8M can help solve this problem by using it as a capsaicinoid content enhancer when it is incubated with intact pepper cells and when it is used directly in various pharmacological and commercial preparations. According to the present disclosure, in some embodiments, identification of genes associated with the biosynthesis of 8M will facilitate increased capsaicinoid production by bioconversion in modified microorganisms.
[0014] When extracting from plants, usually, solid-liquid extraction using solvents such as hexane, chloroform and ethanol is commonly used in capsaicin recovery (Catchpole et al., 2003). However, solvent extraction itself is energy intensive, causes the problem of toxic waste disposal, requires extensive planting areas for plant self-growth, and produces products that need to be further purified to reclaim trace components such as 8M. Therefore, new production methods are needed to reduce the cost of recovery of pure capsaicin or 8M production and / or other capsaicinoids, and to reduce the environmental impact of large-scale cultivation and processing (Yao et al., 1994). The genetic manipulation of selected microbial strains has the potential for improving and increasing the selectivity, abundance and output of specific capsaicinoids to solve these needs.
[0015] It is estimated that approximately 60% of pure capsaicin produced is used as a raw material or ingredient in pharmaceuticals, approximately 15% is used in pesticides, and the remainder is used as a food additive. As of 2016, the current international market price for capsaicin extract is approximately $5,000 per kilogram, with global annual production of 1,200 tons.
[0016] In addition to the above, while consumers approve of and actively seek natural and biological sources for food, fragrances, flavors, or pharmaceutical ingredients, they are also concerned about sourcing, consistent efficacy, and environmentally sustainable production. In this context, the microbial fermentation and production methods of the present disclosure provide compounds produced by modified microbial strains that have the ability to biologically produce products in quantities that can be used in a variety of industries and research, while performing such production in a more natural manner than organic chemical synthesis.
[0017] In the past thirty years, what has become apparent is that the fossil fuel reserves in the world have gradually reduced and will finally be exhausted, and will not satisfy global needs and / or will be too costly and cannot be recovered.To this end, the development of renewable resources has become the focus of government and scientist's attention.In this regard, the disclosure provides the production of medium-chain (C8-C14) branched-chain fatty acids, if this lipid acid is produced in a large amount, will provide the basis for the biofuel of enhancing together with other beneficial effects provided herein.Therefore, component of the disclosure is paid attention to the microbial fatty acid biosynthesis, and its purpose is to produce medium-chain fatty acids or derivatives thereof for the production of diesel.
[0018] In some embodiments, the method for producing fatty acids of the present invention provides the microorganism production of medium chain (C8-C14) free fatty acids (FFA) of biofuel. Such method will help fast production time and renewable properties. It will also avoid using otherwise occupied agricultural land, thereby growing food for increasing population.
[0019] Therefore, there is a need to develop a novel method for producing specific capsaicin intermediates such as 8M for consumer or industrial needs. Specifically, in some embodiments, the present disclosure provides methods for producing 8M in commercially relevant quantities by fermentation processes. Summary of the Invention
[0020] The present disclosure includes improved methods for producing 8-methylnonanoic acid. In some embodiments, the present disclosure provides methods for producing 8-methylnonanoic acid in modified microorganisms such as yeast or bacteria comprising a cell system. According to the present disclosure, a microbial fermentation method for synthesizing 8M is provided. In some embodiments, when the modified microbial strain is fed with a natural precursor (such as glucose or isobutyric acid), the culture of the present disclosure can produce 8M. The identification of genes related to 8M production, such as FatB and KASIII, is also an essential part of the present disclosure.
[0021] Because branched fatty acids are superior to the low temperature operability of straight-chain fuel, therefore in biofuel research field, described the microbial fermentation method (people such as Howard, 2013 of several production branched long-chain fatty acids; People such as Haushalter, 2014; People such as Jiang, 2015; People such as Tao, 2015; And, People such as Bentley, 2016).However, not yet about can use microbial fermentation technology or method (such as provided herein) to produce the report of branched medium-chain fatty acids.
[0022] like Figure 1 As shown, acyl-ACP thioesterase controls the chain length of fatty acids and is one of the key enzymes in the 8M biosynthesis pathway. However, no such 8M-specific thioesterase has been characterized to date. Aluru et al. (2003) used differential expression technology to isolate the FatA gene (GenBank: AF318288.1) from pepper fruit and theoretically proposed that this thioesterase may be involved in 8M biosynthesis ( Figure 1 , Stewart et al., 2007). However, Aluru et al. did not provide a biochemical activity for FatA, and no studies have reported this characterization of FatA since then. Using bioinformatics tools, Mazourek et al. (2009) isolated another acyl-ACP thioesterase, FatB, from pepper (GenBank: EU616562). Again, FatB has not been previously characterized, and its role in 8M biosynthesis remains unknown. In this patent application, the identification of a third acyl-ACP thioesterase gene from the genome of sweet pepper (C. annuum L_Zunla-1) is reported (Qin et al., 2014) and designated FatB2 (NCBI Reference Sequence: XM_016708605.1). FatB2 has 372 aa, including a 64-aa signal peptide that specifies its chloroplast targeting (see SEQ ID NOs: 1 to 5).
[0023] In some embodiments, the present method provides a method for developing bacterial strains that can produce large amounts of 8-methylnonanoic acid through genetic modification and targeted feeding of more cost-effective and readily available specific starting molecules. According to some embodiments of the present disclosure, the production of isobutyryl-CoA is a key intermediate. Once it is produced, KASIIIa / KASIIIb participates in its extension, and thioesterases (FatB / FatB2) control the length of the extended fatty acid. 8M is produced after three rounds of extension and cleavage by FatB / FatB2. (See SEQ ID NOs: 6 to 9). Additional rounds may be included to further extend the fatty acid thus produced.
[0024] One embodiment of the present disclosure is to develop a biosynthetic method for 8-methylnonanoic acid by producing isobutyryl-CoA from glucose or isobutyrate.
[0025] In this disclosure, three methods for producing isobutyryl-CoA are presented: 1) de novo from glucose / pyruvate; 2) by ACS (AAE, acyl-CoA synthetase); and 3) by PCT (propionate CoA-transferase). In some embodiments, this intermediate itself is key to microbial production of 8M.
[0026] In an alternative embodiment, feeding glucose to the cell system comprises expressing a gene for de novo biosynthesis of isobutyryl-CoA in the cell system. Isobutyrate is fed to a cell system expressing an isobutyryl-CoA synthetase (ACS) gene or a propionate / isobutyrate-CoA transferase (PCT) gene.
[0027] This disclosure provides, in part, three pathways for isobutyryl-CoA formation (see publications cited below for additional pathway information), followed by production of branched medium-chain fatty acids in engineered microorganisms:
[0028] 1. De novo synthesis using alsS, ilvC, ilvD, and bkd genes (Jiang et al.);
[0029] 2. Using the ACS (AAE) approach (Zhang et al.); and,
[0030] 3. Use the PCT approach (McMahon MD et al).
[0031] In terms of product / commercial availability, there are dozens of products containing capsaicin or close analogs, such as 8M, on the U.S. market, and they can be used in everything from painkillers to insect repellents, as well as in food and as a sports supplement. Products containing 8M can be aerosol, liquid, or granular formulations.
[0032] According to some embodiments of the present disclosure, medium-chain (C8 to C14) branched-chain fatty acids (BCFA) can be produced for biofuel production. These molecules are important in the development of biofuels because they enhance the operating temperature range of the fuel, especially in developing fuels with excellent cold flow properties. In contrast, single-chain fatty acids (SCFA) appear to be more easily produced via microbial bioconversion. The cellular synthesis of both SCFA and BCFA requires a FabH enzyme that can catalyze the condensation reaction between malonyl-ACP and short-chain acyl-CoA.
[0033] In some aspects, the present disclosure provides a biosynthetic method for preparing capsaicin 8-methylnonanoic acid (8M), which comprises (a) expressing KASIIIa, KASIIIb, and a thioesterase in a transformed cell system; (b) producing isobutyryl-CoA in the transformed cell system; and (c) producing 8-methylnonanoic acid.
[0034] In some embodiments of the method, the thioesterase is FATB or FATB2. In some embodiments of the method, KASIIIa is cloned from a Capsicum plant (e.g., Capsicum annuum). In some embodiments of the method, KASIIIb is cloned from a Capsicum plant (e.g., Capsicum annuum). In some embodiments of the method, the thioesterase is FATB2 and is cloned from a Capsicum plant (e.g., Capsicum annuum). In some embodiments of the method, the thioesterase is FATB and is cloned from a Capsicum plant (e.g., Capsicum annuum).
[0035] In some embodiments of the method, the cell system further comprises a glucose medium for the transformed cell system. In some embodiments of the method, the cell system further comprises a pyruvate medium for the transformed cell system.
[0036] In some embodiments of the method, the transformed cell system further comprises an acyl-CoA synthetase. In some embodiments of the method, the transformed cell system further comprises a propionate CoA transferase.
[0037] In some embodiments of the method, the transformed cell system is selected from the group consisting of yeast, non-capsaicinoid-producing plants, algae, and bacteria. In some embodiments of the method, the cell system is Escherichia coli. In some embodiments of the method, the cell system is selected from the group consisting of bacteria, yeast, plant cells, animal cells, in vitro translation systems, and combinations thereof. In some embodiments of the method, the transformed cell system is a microbial culture of yeast or bacteria.
[0038] In some embodiments of the method, 8M is purified. In some embodiments of the method, 8M is greater than 70% (e.g., greater than 70%, greater than 80%, greater than 90%, greater than 95%, greater than 98%, or greater than 99%) pure. In some embodiments of the method, the 8M content is greater than about 85% by weight (e.g., greater than about 85% by weight, greater than about 90% by weight, greater than about 95% by weight, greater than about 98% by weight, greater than about 99% by weight) on a dry weight basis.
[0039] In some embodiments of the method, step c) comprises: i) purifying the crude product; and ii) removing the solvent under vacuum to provide a concentrated capsaicinoid product. In some embodiments of the method, the crude product is purified by column chromatography. In some embodiments of the method, the crude product is purified by acid-base extraction. In some embodiments of the method, the crude product is purified by vacuum distillation. In some embodiments of the method, the crude product is purified by semi-preparative HPLC.
[0040] In other aspects, the present disclosure provides a thioesterase gene having a nucleic acid sequence of SEQ ID NO. 5 or a nucleic acid sequence that is at least 80% (e.g., at least 80%, at least 90%, at least 95%, at least 98%, or at least 99%) identical to SEQ ID NO. 5. In some embodiments, the gene is in a host cell (e.g., a bacterial cell, a yeast cell, a plant cell, or an animal cell). In some embodiments, the gene is in an Escherichia coli cell.
[0041] In other aspects, the present disclosure provides a modified KasIIIa gene having a nucleic acid sequence of SEQ ID NO.6 or a nucleic acid sequence having at least 80% (e.g., at least 80%, at least 90%, at least 95%, at least 98%, or at least 99%) identity to SEQ ID NO.6. In some embodiments, the gene is in a host cell (e.g., a bacterial cell, a yeast cell, a plant cell, or an animal cell). In some embodiments, the gene is in an Escherichia coli cell.
[0042] In other aspects, the present disclosure provides a modified KasIIIb gene having a nucleic acid sequence of SEQ ID NO. 7 or a nucleic acid sequence having at least 80% (e.g., at least 80%, at least 90%, at least 95%, at least 98%, or at least 99%) identity to SEQ ID NO. 7. In some embodiments, the gene is in a host cell (e.g., a bacterial cell, a yeast cell, a plant cell, or an animal cell). In some embodiments, the gene is in an Escherichia coli cell.
[0043] In other aspects, the present disclosure provides a modified CCL4 gene having a nucleic acid sequence of SEQ ID NO. 8 or a nucleic acid sequence having at least 80% (e.g., at least 80%, at least 90%, at least 95%, at least 98%, or at least 99%) identity to SEQ ID NO. 8. In some embodiments, the gene is in a host cell (e.g., a bacterial cell, a yeast cell, a plant cell, or an animal cell). In some embodiments, the gene is in an E. coli cell.
[0044] In other aspects, the present disclosure provides a modified PCT gene having a nucleic acid sequence of SEQ ID NO. 9 or a nucleic acid sequence having at least 80% (e.g., at least 80%, at least 90%, at least 95%, at least 98%, or at least 99%) identity to SEQ ID NO. 9. In some embodiments, the gene is in a host cell (e.g., a bacterial cell, a yeast cell, a plant cell, or an animal cell). In some embodiments, the gene is in an E. coli cell.
[0045] In other aspects, the present disclosure provides a Fat2B protein having the amino acid sequence of SEQ ID NO. 2 or an amino acid sequence having at least 80% (e.g., at least 80%, at least 90%, at least 95%, at least 98%, or at least 99%) identity to SEQ ID NO. 2. In some embodiments, the protein is in a host cell (e.g., a bacterial cell, a yeast cell, a plant cell, or an animal cell). In some embodiments, the protein is in an E. coli cell.
[0046] In other aspects, the present disclosure provides a protein comprising an amino acid sequence derived from translating the nucleic acid sequence of SEQ ID NO. 5. In some embodiments, the protein is in a host cell (e.g., a bacterial cell, a yeast cell, a plant cell, or an animal cell). In some embodiments, the protein is in an Escherichia coli cell.
[0047] In other aspects, the present disclosure provides a biosynthetic method for producing medium-chain BCFAs (branched-chain fatty acids), comprising: (a) expressing KASIIIa, KASIIIb, and a thioesterase in a transformed cell system; (b) producing isobutyryl-CoA in the transformed cell system; and (c) producing C8 to C14 branched-chain fatty acids. In some embodiments of the method, the branched-chain fatty acids produced are used for biofuel production. In some embodiments of the method, the branched-chain fatty acids produced are used for biofuel production and have enhanced cold flow properties. In some embodiments of the method, the method further comprises using FabH and isobutyryl-CoA to produce a fatty acid synthase (FAS) system for elongation of branched-chain fatty acids. In some embodiments of the method, the method further comprises feeding α-ketoisovalerate or its sodium salt to the transformed cell system to express 8M. In some embodiments of the method, the method further comprises expressing bkd in the transformed cell system. In some embodiments of the method, the method further comprises feeding isobutyrate and / or its salts to the transformed cell system to express 8M. In some embodiments of the method, the method further comprises expressing CCL4 in the transformed cell system. In some embodiments of the method, the method further comprises feeding isobutyric acid and / or a salt thereof to the transformed cell system to express 8M. In some embodiments of the method, the method further comprises expressing PCT in the transformed cell system. In some embodiments of the method, the method further comprises feeding isobutyric acid and / or a salt thereof to the transformed cell system to express 8M. In some embodiments of the method, the method further comprises expressing alsS, ilvC, ilvD, and bkd in the transformed cell system.
[0048] In some embodiments of the method, the transformed cell system is selected from the group consisting of yeast, non-capsaicinoid-producing plants, algae, and bacteria. In some embodiments of the method, the cell system is Escherichia coli. In some embodiments of the method, the cell system is selected from the group consisting of bacteria, yeast, plant cells, animal cells, in vitro translation systems, and combinations thereof. In some embodiments of the method, the transformed cell system is a microbial culture of yeast or bacteria.
[0049] In some embodiments of the method, the branched-chain fatty acids and / or 8M are purified. In some embodiments of the method, the branched-chain fatty acids and / or 8M are greater than 70% (e.g., greater than 70%, greater than 80%, greater than 90%, greater than 95%, greater than 98%, or greater than 99%) pure. In some embodiments of the method, the branched-chain fatty acids and / or 8M content is greater than about 85% by weight (e.g., greater than about 85% by weight, greater than about 90% by weight, greater than about 95% by weight, greater than about 98% by weight, greater than about 99% by weight) based on dry weight.
[0050] In some embodiments of the method, step c) comprises: i) purifying the crude product; and ii) removing the solvent under vacuum to provide a concentrated branched-chain fatty acid and / or 8M product. In some embodiments of the method, the crude product is purified by column chromatography. In some embodiments of the method, the crude product is purified by acid-base extraction. In some embodiments of the method, the crude product is purified by vacuum distillation. In some embodiments of the method, the crude product is purified by semi-preparative HPLC.
[0051] As for the cell system, in some embodiments, it is selected from the group consisting of bacteria, yeast and combinations thereof, or any cell system that can allow genetic transformation with a selected gene and thereafter biosynthesize the desired 8-methylnonanoic acid from a feedstock glucose (de novo synthesis pathway) or isobutyric acid (ACS or PCT pathway) precursor. In the most preferred microbial system, E. coli is used to produce the desired 8M.
[0052] While the present disclosure is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will be described in detail herein. However, it should be understood that the drawings and detailed description provided herein are not intended to limit the disclosure to the specific embodiments disclosed, but on the contrary, the intent is to cover all modifications, equivalents, and alternative forms that fall within the spirit and scope of the disclosure as defined by the appended claims.
[0053] Other features and advantages of the present invention will become apparent from the following detailed description of preferred embodiments of the invention when taken in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] Figure 1 Capsaicinoid biosynthetic pathway. Aminotransferase (pAMT) catalyzes the formation of vanillylamine from vanillin. Pal, phenylalanine ammonia-lyase; Ca4H, cinnamate 4-hydroxylase; 4Cl, 4-coumarate CoA ligase; HCT, hydroxycinnamoyltransferase; C3H, coumaroylshikimate / quinate 3-hydroxylase; COMT, caffeic acid O-methyltransferase; pAMT, aminotransferase; BCAT, branched-chain amino acid transferase; Kas, 3-keto-acyl ACP synthase; ACL, acyl carrier protein; Fat, acyl-ACP thioesterase; ACS, acyl-CoA synthetase; CS, capsaicin synthase (Stewart C et al. 2007, J. Exp. Bot. 58:979-991).
[0055] Figure 2Activity of purified FatA (TE1, left bar of each pair) and FatB (TE2, right bar of each pair) proteins against various acyl-CoAs. Acyl-CoAs were purchased from Sigma (St Louis, MO). Thioesterase (TE) activity was determined at 30°C in 100 mM Tris buffer (pH 7.5) containing 100 mg / L acyl-CoAs and 5 μl of purified enzyme. Free CoA and acyl-CoAs were analyzed by HPLC. HPLC was performed by Dionex- 3000LC system (Thermo Scientific) was used. A 120CI 8 reverse phase column (Thermo Scientific; 3μ, 120A, 150x3mm) was used. The mobile phase consisted of solvent A (0.1% trifluoroacetic acid) and solvent B (acetonitrile). The gradient elution program was as follows: 5% B from 0 min to 5 min; a linear gradient from 5% to 80% B from 5 min to 9 min; 80% B from 9 min to 11 min; and 5% B from 11 min to 12 min. The flow rate was 0.6 ml / min. A diode array detector collected data from 200 nm to 400 nm. For detection and quantification of substrates and products, peak areas were measured at 257 nm. Due to the unavailability of commercial acyl-ACPs, various acyl-CoAs from Sigma were used as substrates for the thioesterase.
[0056] Figure 3 GC / MS analysis of supernatants from IPTG-induced BL21(DE3) cultures. GC / MS analysis of supernatants from IPTG-induced BL21(DE3) cultures. CK, BL21(DE3) with empty vector; TE1, FatA; TE2, FatB; TE3, FatB2. Following induction with 1 mM IPTG, cultures were grown at 16°C, and fatty acids were extracted from the supernatants one day later.
[0057] Figure 4 : cis-5-dodecenoic acid (CAS No. 2430-94-6).
[0058] Figure 5 8M was produced in strains harboring different FabH genes. KBB, KAS IIIb; KAB, KAS IIIa; KBsB1, FabH2 from Bacillus subtilis 168; and KSaB, FabH from Staphylococcus aureus. KBsB and KSaB served as positive controls (Jiang et al., 2015). This experiment was performed in triplicate.
[0059] Figure 6 : MS spectra of the putative 8M peak and 8M standard, and GC profile of the 8M standard. The lower spectrum is the library match.
[0060] Figure 7 : 8M production in strains harboring CCL4, FaB2, and different FabH genes. BBA, KAS IIIb; ABA, KAS IIIa; BsBA1 from Bacillus subtilis 168, FabH2; SaBA from Staphylococcus aureus, FabH. This experiment was performed in triplicate.
[0061] Figure 8 : 8M was synthesized de novo in E. coli. 8M was synthesized de novo in E. coli. Coloring genes are those that were engineered. alsS and bkd are from Bacillus subtilis 168; ilvC and ilvD are from E. coli; KASIIIa / KASIIIb and FatB / FatB2 are from pepper. This figure is adapted from Jiang et al. (2015) Figure 1 Adapted. (See SEQ ID NOs: 1 to 7).
[0062] Description of the Preferred Embodiments
[0063] Explanation of terms used in this article :
[0064] Capsaicin or CP It is a colorless irritant phenolamide C 18 H 27 NO3, and is one of a series of phenolamides present in various species of pepper and their hybrids that give peppers their spicy or pungent flavor and are used in food, pharmaceutical, and safety applications. Pure CP is a volatile, hydrophobic, colorless, odorless, crystalline to waxy compound.
[0065] As used herein, Capsaicin Capsaicinoids refer to a class of pungent compounds related to capsaicinoids, which are responsible for the heat of red peppers. They are irritants to mammals (including humans) and produce a burning sensation in any tissue they come into contact with. Capsaicinoids, including 8M, are produced by red peppers as secondary metabolites that act as deterrents to certain mammals and fungi.
[0066] Cell System Any cell that provides ectopic protein expression. It includes bacteria, yeast, plant cells, and animal cells. It includes both prokaryotic and eukaryotic cells. It also includes in vitro expression of proteins based on cellular components (such as ribosomes).
[0067] Fatty acids, C8-C14According to the present disclosure, a variety of fatty acids can be used as raw materials. Source materials include vanillin, vanillinamine, or derivatives thereof with modifications on the aromatic ring (such as methylation, ethylation, or glycosylation); and more specifically, 8-14 carbon straight-chain or branched fatty acids or derivatives thereof, such as hydroxy fatty acids (e.g., octanoic acid; nonanoic acid; decanoic acid; undecanoic acid; and dodecanoic acid), which can be straight-chain or branched fatty acids, can be used to produce 8-methylnonanoic acid of the present disclosure.
[0068] Grow the cell system: Growth includes providing an appropriate culture medium that allows the cells to multiply and divide. It also includes providing resources so that the cells or cell components can translate and produce recombinant proteins.
[0069] Protein expression Transfection: Protein production can occur after gene expression. It consists of the stage after DNA has been transcribed into messenger RNA (mRNA). The mRNA is then translated into a polypeptide chain, which is ultimately folded into a protein. DNA is present in cells through transfection, a method for intentionally introducing nucleic acids into cells. This term is commonly used for non-viral methods in eukaryotic cells. It can also relate to other methods and cell types, but other terms are preferred: "transformation" is more commonly used to describe bacteria, non-animal eukaryotic cells, including non-viral DNA transfer in plant cells. In animal cells, transfection is a preferred term because transformation is also used to refer to the progression of cancerous states (carcinogenesis) in these cells. Transduction is commonly used to describe viral-mediated DNA transfer. Transformation, transduction, and viral infection are included under the definition of transfection in this application.
[0070] yeast Yeast, as claimed herein, according to the present disclosure, is a eukaryotic, unicellular microorganism classified as a member of the kingdom Fungi. Yeast is a unicellular organism that evolved from a multicellular ancestor, but some species useful in the present disclosure are those that can develop multicellular properties by forming strings of connected budding cells known as pseudohyphae or pseudohyphae.
[0071] Acronyms :
[0072] AAE, acyl activating enzyme
[0073] PCT, propionate / isobutyrate-CoA transferase
[0074] TE, acyl-ACP thioesterase
[0075] Pal, phenylalanine ammonia lyase;
[0076] Ca4H, cinnamate 4-hydroxylase;
[0077] 4Cl, 4-coumarate CoA ligase;
[0078] HCT, hydroxycinnamoyltransferase;
[0079] C3H, coumaroylshikimate / quinate 3-hydroxylase;
[0080] COMT, caffeic acid O-methyltransferase; pAMT, aminotransferase;
[0081] BCAT, branched-chain amino acid transferase;
[0082] KAS, 3-keto-acyl ACP synthase;
[0083] ACL, acyl carrier protein;
[0084] FatA, acyl-ACP thioesterase;
[0085] ACS, acyl-CoA synthetase; and
[0086] CS, capsaicin synthase. DETAILED DESCRIPTION
[0087] The present disclosure provides, in part, a microbial fermentation system for producing 8M.
[0088] Due to the low-temperature operability of branched-chain fatty acids over straight-chain fuels, several microbial fermentation methods for producing branched long-chain fatty acids have been described in the field of biofuel research (Howard et al., 2013; Haushalter et al., 2014; Jiang et al., 2015; Tao et al., 2015; Bentley et al., 2016). However, there are no reports on the production of branched medium-chain fatty acids using microbial fermentation.
[0089] like Figure 1 As shown, acyl-ACP thioesterase controls the chain length of fatty acids and is one of the key enzymes in the 8M biosynthesis pathway. However, such 8M-specific thioesterases have not been characterized to date. Aluru et al. (2003) isolated the FatA gene (GenBank: AF318288.1) from pepper fruit based on differential expression and believed that this thioesterase is involved in 8M biosynthesis ( Figure 1, Stewart et al., 2007). However, the biochemical activity of FatA has not been reported to date. Using bioinformatics tools, Mazourek et al. (2009) isolated another acyl-ACP thioesterase, FatB, from pepper (GenBank: EU616562). However, FatB has not been characterized to date, and its role in 8M biosynthesis remains unknown. In this patent application, the identification of a third acyl-ACP thioesterase gene from the genome of sweet pepper Zunla-1 (C. annuum L. Zunla-1) is reported (Qin et al., 2014) and named FatB2 (NCBI Reference Sequence: XM_016708605.1). FatB2 has 372 aa, including a 64-aa signal peptide for chloroplast targeting (see SEQ ID NOs: 1 to 5).
[0090] The 8M produced herein was synthesized in a modified E. coli culture that was modified to carry the KASIIIa / KASIIIb and FatB / FatB2 genes from pepper, as well as other genes associated with the production of isobutyryl-CoA. (See SEQ ID NOs: 1 to 6). Isobutyryl-CoA can be synthesized de novo from glucose by overexpression of the alsS, ilvC, ilvD, and bkd genes. Alternatively, isobutyryl-CoA can be produced from the feedstock isobutyric acid by overexpression of the ACS (isobutyryl-CoA synthetase) or PCT (propionate CoA transferase) genes. These genes allow the selected strain, when fed with appropriate feedstock, to synthesize 8-methylnonanoic acid ( Figure 8 ).
[0091] Organic or non-biological methods for synthesizing capsaicin and its analogs have been reported, for example, an inorganic synthesis of capsaicin (N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide, the active ingredient in red pepper) is described by Crombie et al. (J. Chem Soc., 1025-27 (1955)). Other organic pathways have been shown in U.S. Pat. No. 4,493,848 to LaHann et al. and U.S. Pat. No. 5,094,782 to Chen et al.
[0092] Capsaicin has long been used as an experimental tool because it selectively acts on small-diameter afferent nerve fibers, C-fibers and A-delta fibers, which are believed to transmit pain signals. Animal studies have shown that capsaicin triggers C-fiber membrane depolarization by opening cation channels permeable to calcium and sodium. One of the receptors responsible for capsaicin's effects has recently been cloned.
[0093] In most red peppers, vanillinamine is formed from phenylalanine via ferulic acid, vanillin, and related compounds, and capsaicinoids are produced from vanillylamine and branched-chain fatty acids by capsaicin synthase ( Figure 1 ).
[0094] synthetic biology
[0095] Genetically engineered microorganisms have become an increasingly important platform for the production of pharmaceuticals, chemicals, and biofuels from renewable resources (Du et al., 2011). When used in food, these biotechnology products can be labeled as “natural” in the food sector under current regulations ( and Münch, 1997).
[0096] Exemplary capsaicinoids include, but are not limited to, norvanillin, N-vanillin nonamide, N-vanillin sulfonamide, N-vanillin urea, N-vanillin carbamate, N[(substituted phenyl)methyl]alkylamides, methylene-substituted N[(substituted phenyl)methyl]alkanoamides, N[(substituted phenyl)methyl]-cis-monosaturated alkenamides, N[(substituted phenyl)methyl]diunsaturated amides, 8M, 3-hydroxyacetanilide, hydroxyphenylacetamide, pseudocapsaicin, dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin, homodihydrocapsaicin I, anandamide, piperine, zingerone, holosinaldehyde, polygonial, aframodial, cinnamodial, cinnamosmolide, cinnamolide, civamde, norvanillin, avanafil, N-oleyl-homofuranopyrimidine, scutellaria-type compounds, scalaradial, ancistrodial, and combinations or mixtures thereof.
[0097] Determining sequence similarity using hybridization techniques
[0098] Nucleic acid hybridization is a technique well known to those skilled in the art of DNA manipulation. The hybridization properties of a given pair of nucleic acids are an indication of their similarity or identity.
[0099] The term "hybridization" generally refers to the ability of nucleic acid molecules to be connected via complementary base chain pairing. When contacting nucleic acid molecules under appropriate conditions, such hybridization can occur. "Specific hybridization" refers to the ability of two nucleic acid molecules to form an antiparallel double-stranded nucleic acid structure. If a nucleic acid molecule shows "complete complementarity", that is, each nucleotide in a sequence is complementary to the base pairing partner nucleotide in another sequence, it is considered to be the "complement" of another nucleic acid molecule. If two molecules can hybridize with each other with enough stability to allow them to keep annealing to each other under at least conventional "low stringency" conditions, it is considered to be "minimally complementary". Similarly, if molecules can hybridize with each other with enough stability to allow them to keep annealing to each other under conventional "high stringency" conditions, it is considered to be "complementary". For example, at least under low stringency conditions, nucleic acid molecules that hybridize with other nucleic acid molecules are referred to as "hybridizable homologs" of other nucleic acid molecules. Conventional low and high stringency conditions are described herein and in Sambrook et al., Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Press, Cold Spring Harbor, New York (1989) and in Haymes et al., Nucleic Acid Hybridization, A Practical Approach, IRL Press, Washington, DC (1985). Deviations from complete complementarity are permissible as long as such deviations do not completely eliminate the ability of the molecules to form a double-stranded structure.
[0100] Low stringency conditions can be used to select nucleic acid sequences that have a lower degree of sequence identity with the target nucleic acid sequence. It may be desirable to employ conditions such as about 0.15 M to about 0.9 M sodium chloride at a temperature in the range of about 20° C. to about 55° C. High stringency conditions can be used to select nucleic acid sequences that have a higher degree of identity with the nucleic acid sequences disclosed herein (Sambrook et al., 1989). High stringency conditions typically involve hybridizing the nucleic acids in about 2X to about 10X SSC (diluted from a 20X SSC stock solution containing 3M sodium chloride and 0.3M sodium citrate in distilled water, pH 7.0), about 2.5X to about 5X Denhardt's solution (diluted from a 50X stock solution containing 1% (w / v) bovine serum albumin, 1% (w / v) polysucrose, and 1% (w / v) polyvinylpyrrolidone in distilled water), about 10 mg / mL to about 100 mg / mL fish sperm DNA, and about 0.02% (w / v) to about 0.1% (w / v) SDS, and incubating at about 50° C. to about 70° C. for several hours to overnight. High stringency conditions are preferably provided by 6X SSC, 5X Denhardt's solution, 100 mg / mL fish sperm DNA, and 0.1% (w / v) SDS, and incubating at 55° C. for several hours. Hybridization is generally followed by several washing steps. The washing composition generally comprises 0.5X to about 10X SSC and 0.01% (w / v) to about 0.5% (w / v) SDS and is incubated at about 20°C to about 70°C for 15 minutes. Preferably, the nucleic acid fragments remain hybridized after at least one wash in 0.1X SSC at 65°C.
[0101] Analyzing sequence similarity using identity scores
[0102] As used herein, "sequence identity" refers to the degree to which two optimally aligned polynucleotide or peptide sequences are invariant in components (e.g., nucleotides or amino acids) over the entire alignment window. The "identity score" for an aligned segment of a test sequence and a reference sequence is the number of identical components shared by the two aligned sequences divided by the total number of components in the segment of the reference sequence, i.e., the entire reference sequence or a smaller, defined portion of the reference sequence.
[0103] As used herein, the term "percent sequence identity" or "percent identity" refers to the percentage of identical nucleotides in the linear polynucleotide sequence of a reference ("query") polynucleotide molecule (or its complementary strand) compared to a test ("subject") polynucleotide molecule (or its complementary strand) when the two sequences are optimally aligned (with appropriate nucleotide insertions, deletions, or gaps totaling less than 20% of the reference sequence over the comparison window). Optimal alignment of sequences for aligning a comparison window is well known to those skilled in the art and can be performed by tools such as the local homology algorithm of Smith and Waterman, the homology alignment algorithm of Needleman and Wunsch, the search similarity method of Pearson and Lipman, and preferably by computer implementations of these algorithms, such as those described herein. Wisconsin The "identity score" of the aligned fragment of a test sequence and a reference sequence is the number of identical components shared by the two aligned sequences divided by the total number of components in the reference sequence fragment, i.e., the entire reference sequence or a smaller, limited portion of the reference sequence. Percent sequence identity is expressed as the identity score multiplied by 100. The comparison of one or more polynucleotide sequences can involve full-length polynucleotide sequences or portions thereof, or longer polynucleotide sequences. For purposes of this disclosure, BLASTX version 2.0 (for translated nucleotide sequences) and BLASTN version 2.0 (for polynucleotide sequences) can also be used to determine "percent identity."
[0104] The percent sequence identity is preferably determined using the Sequence Analysis Software Package TMThe "best fit" or "gap" program (version 10; Genetics Computer Group, Inc., Madison, WI) is used to determine. "Gap" uses the algorithm of Needleman and Wunsch (Needleman and Wunsch, Journal of Molecular Biology 48:443-453, 1970) to find the alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. "Best fit" uses the local homology algorithm of Smith and Waterman (Smith and Waterman, Advances in Applied Mathematics, 2:482-489, 1981, Smith et al., Nucleic Acids Research 11:2205-2220, 1983) to perform the best alignment of the best segment similarity between the two sequences and insert gaps to maximize the number of matches. Percent identity is most preferably determined using the "best fit" program.
[0105] Useful methods for determining sequence identity are also disclosed in the Basic Local Alignment Search Tool (BLAST) program, which is publicly available from the National Center Biotechnology Information (NCBI), National Library of Medicine, National Institute of Health, Bethesda, Md. 20894; see BLAST Manual, Altschul et al., NCBI, NLM, NIH; Altschul et al., J. Mol. Biol. 215:403-410 (1990); version 2.0 or later of the BLAST program allows gaps (deletions and insertions) to be introduced into the alignment; for peptide sequences, BLASTX can be used to determine sequence identity; and, for polynucleotide sequences, BLASTN can be used to determine sequence identity.
[0106] As used herein, the term "significant percentage sequence identity" refers to at least about 70% sequence identity, at least about 80% sequence identity, at least about 85% identity, at least about 90% sequence identity, or even greater sequence identity, such as a percentage sequence identity of about 98% or about 99% sequence identity. Thus, one embodiment of the present disclosure is a polynucleotide molecule having at least about 70% sequence identity, at least about 80% sequence identity, at least about 85% identity, at least about 90% sequence identity, or even greater sequence identity, such as about 98% or about 99% sequence identity, to the polynucleotide sequences described herein. Polynucleotide molecules having the activity of the ACS and CS genes of the present disclosure are capable of directing the production of a variety of capsaicinoids and have significant percentage sequence identity to the polynucleotide sequences provided herein and are included within the scope of the present disclosure.
[0107] "Homology" refers to the level of similarity between two or more nucleic acid or amino acid sequences in terms of percent positional identity (ie, sequence similarity or identity). Homology also refers to the concept of similar functional properties between different nucleic acids or proteins.
[0108] In alternative embodiments, the nucleic acid molecule comprises a nucleic acid sequence that exhibits 70% or greater identity to a nucleic acid molecule selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 9, or any other nucleic acid sequence described herein, any complementary sequence thereof, any fragment thereof, or any cis-element thereof, and more preferably at least 80% or greater, 85% or greater, 87% or greater, 88% or greater, 89% or greater, 90% or greater, 91% or greater, 92% or greater, 93% or greater, 94% or greater, 95% or greater, 96% or greater, 97% or greater, 98% or greater, or 99% or greater identity. The nucleic acid molecule preferably comprises a nucleic acid sequence that exhibits 75% or greater sequence identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 9, or any other nucleic acid sequence described herein, any complementary sequence thereof, any fragment thereof, or any cis-element thereof. More preferably, the nucleic acid molecule comprises a nucleic acid sequence that exhibits 80% or greater sequence identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 9, or any other nucleic acid sequence described herein, any complementary sequence thereof, any fragment thereof, or any cis-element thereof. Most preferably, the nucleic acid molecule comprises a nucleic acid sequence that exhibits 85% or greater sequence identity to a polynucleotide selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 9, or any other nucleic acid sequence described herein, any complementary sequence thereof, any fragment thereof, or any cis-element thereof.
[0109] For the purposes of this disclosure, "percent identity" can also be determined using BLASTX version 2.0 (for translated nucleotide sequences) and BLASTN version 2.0 (for polynucleotide sequences). In a preferred embodiment of the present disclosure, the maize genomic promoter sequences disclosed herein comprise nucleic acid molecules or fragments with a BLAST score greater than 200, preferably a BLAST score greater than 300, and even more preferably a BLAST score greater than 400, and their respective homologs.
[0110] According to another embodiment of the present disclosure, the efficiency of heterologous protein production in microbial systems can be enhanced by codon changes that change the DNA sequence to a DNA sequence that is preferred by the cell system used for expression, but different from the original gene source organism, without changing the final polypeptide produced. Methods commonly used to overcome this problem include targeted mutagenesis to remove rare codons or adding rare codon tRNAs in specific cell lines to move towards codon sequences preferred by the host organism that will produce the polypeptide of interest. Recently, improvements in such "codon optimization" technologies have enabled the cost-effective production of synthetic genes, making it a viable alternative and potentially useful in the present disclosure.
[0111] Identity and Similarity
[0112] Identity is the fraction of identical amino acids between a pair of sequences after aligning the sequences (which can be done using only sequence information or structural information or some other information, but typically it is based on sequence information alone), while similarity is a score assigned based on an alignment using some similarity matrix. The similarity index can be any of the following BLOSUM62, PAM250, or GONNET, or any matrix used by those skilled in the art for protein sequence alignment.
[0113] Identity is the degree of similarity between two subsequences (without gaps between the sequences). 25% or greater identity indicates functional similarity, whereas 18% to 25% indicates structural or functional similarity. Remember that two completely unrelated or random sequences (which are more than 100 residues) can have greater than 20% identity. Similarity is the degree to which two sequences are similar when compared. This is determined by their identity.
[0114] As will be apparent from the foregoing description, certain aspects of the present disclosure are not limited to the details of the embodiments described herein, and therefore it is contemplated that other modifications and applications or their equivalents will occur to those skilled in the art. Therefore, the claims should be intended to cover all such modifications and applications that do not depart from the spirit and scope of the present disclosure.
[0115] In addition, unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure, the preferred methods and materials are described above.
[0116] Although the foregoing invention has been described in detail by way of illustration and example for purposes of understanding, it will be apparent to those skilled in the art that certain changes and modifications may be practiced. Therefore, the description and examples should not be construed as limiting the scope of the invention, which is defined by the appended claims.
[0117] Therefore, it should be understood that the embodiments of the present invention provided herein for the production of 8-methylnonanoic acid illustrate the application of the principles of the present invention. From the foregoing description, it will be apparent that changes in the form, methods of use, and applications of the elements of the disclosed production methods and selected microbial strains may be sought without departing from the spirit of the invention or the scope of the appended claims.
[0118] Example
[0119] Example 1
[0120] Cloning and characterization of different pathways
[0121] Previously, an E. coli fermentation platform was developed in which various capsaicinoids can be produced when fed with fatty acids and vanillinamine / vanillin (Chen et al., 2015). This system also demonstrated the production of novanillin. In the present disclosure, this system was used to fully sequence and characterize three capsaicin acyl-ACP thioesterases and thereby elucidate their role in 8M biosynthesis. To facilitate its expression in E. coli, the nucleotide sequence encoding the mature protein without transient peptides was codon-optimized for the E. coli genome and synthesized by GenScript (Piscataway, NJ). The synthesized gene was cloned into the pCDFDuet-1 vector (Spect+) and transformed into BL21 (DE3) for in vitro and in vivo studies.
[0122] like Figure 2 As shown, FatA( Figure 2 TE1 in ) is a long-chain acyl-CoA thioesterase, whereas FatB prefers medium-chain acyl-CoA ( Figure 2 TE2 in ). It appears that FatB, rather than FatA, is involved in 8M biosynthesis. This conclusion is supported by analysis of the fatty acid composition of cell cultures ( Figure 3Peak 1 was identified as cis-5-dodecenoic acid by comparing the retention time and mass spectrum with a cis-5-dodecenoic acid standard from Sigma ( Figure 4 ).like Figure 3 As shown, cis-5-dodecenoic acid was produced by FatB and FatB2, confirming their involvement in 8M production.
[0123] In plants as well as in bacteria, KAS III (β-ketoacyl-ACP synthase III, FabH) catalyzes the condensation of acetyl-CoA and malonyl-CoA, the initial step in the fatty acid biosynthesis pathway, whereas KAS I is involved in fatty acid elongation. In the βM biosynthesis pathway, the KAS III enzyme must be able to accept isobutyryl-CoA as a substrate ( Figure 1 However, although bacterial KASIII enzymes using isobutyryl-CoA as a substrate have been well characterized, such enzymes have not yet been identified in the plant kingdom (Howard et al., 2013; Haushalter et al., 2014; Jiang et al., 2015; Tao et al., 2015; Bentley et al., 2016).
[0124] Using bioinformatics methods, Mazourek et al. (2009) isolated KAS IIIa (EU616569) and KAS IIIb (EU616570) genes from pepper. However, their enzymatic activity and role in 8M biosynthesis have not yet been reported. In the present disclosure, these two KAS III enzymes were characterized to understand their role in 8M biosynthesis. In order to promote its expression in E. coli, the nucleotide sequence encoding the mature protein without transient peptide was codon-optimized for the E. coli genome and synthesized by GenScript (SEQ ID. NO 6 and 7, respectively). The synthesized gene was cloned into the pRSFDuet-1 vector (Kan+) and transformed into BL21 (DE3) containing pCDFDuet-FatB or pCDFDuet-FatB2 for in vivo research.
[0125] However, when KAS IIIa / KAS IIIb was co-expressed with FatB / FatB2 in BL21(DE3) cells, no 8M was produced upon induction by 1 mM IPTG (data not shown), suggesting that endogenous isobutyryl-CoA concentrations may be too low to support 8M biosynthesis. The bkd operon was cloned from the genome of Bacillus subtilis 168, which encodes ketoisovalerate dehydrogenase ( Figure 1) was encoded into the pETDuet-1 vector (AMP+), and bkd was co-expressed with KAS IIIa / KAS IIIb and FatB / FatB2 in BL21 (DE3). After IPTG induction, the cells were fed with 1 g / L α-ketoisovalerate ( Figure 1 ) and then generate 8M( Figure 5 and Figure 6 ).
[0126] As another example, the CCL4 gene from hops (GenBank: AGA17921.1) was synthesized using codon optimization for the E. coli genome. CCL4 encodes isobutyryl-CoA synthetase, which converts isobutyrate to isobutyryl-CoA (Xu et al., 2013). CCL4 was cloned into the pETDuet-1 vector (AMP+) and co-expressed with KAS IIIa / KAS IIIb and FatB / FatB2 in BL21(DE3). After IPTG induction, 8 M ( Figure 7 SEQ ID NOs: 6 and 7 represent optimized KAS nucleic acid sequences from Capsicum annuum. KAS IIIa (EU616569) and KAS IIIb (EU616570) are genes from Capsicum annuum.
[0127] As another example, the PCT gene from Megasphaera elsdenii (NCBI Reference Sequence: WP_014015705.1) was synthesized using codon optimization for the Escherichia coli genome. PCT encodes acetate CoA-transferase, which converts isobutyrate and acetyl-CoA to isobutyryl-CoA and acetate (McMahon and Prather, 2014). PCT was cloned into the pETDuet-1 vector (AMP+) and co-expressed with KAS IIIa / KAS IIIb and FatB / FatB2 in BL21(DE3). After IPTG induction, 8 M was produced when fed 1 g / L of isobutyrate.
[0128] In another example, based on the work of Jiang et al. (2015), the alsS and bkd genes from the Bacillus subtilis 168 genome were cloned into the pETDuet-1 vector together with the KAS IIIa / KAS IIIb pRSFDuet-1 vector, and the ilvC and ilvD genes from the Escherichia coli genome were cloned into the two multiple cloning sites of the pACYCDuet-1 vector (CM+). Figure 8When alsS, ilvC, ilvD, bkd, and KAS IIIa / KAS IIIb genes were co-expressed with FatB / FatB2 in BL21(DE3), 8M was produced by the de novo synthesis pathway after IPTG induction.
[0129] Express
[0130] As described above, to produce 8M, the applicants first prepare isobutyryl-CoA using three methods: de novo synthesis, the ACS (AAE), or the PCT pathway. Isobutyryl-CoA is then used by KAS IIIa or KAS IIIb to enter the fatty acid elongation cycle of a microbial host, such as E. coli. After three rounds of elongation, 8M is released by FatB or FatB2. pRSFDuet-1 is used to express KAS IIIa or KAS IIIb; pCDFDuet-1 is used to express FatB or FatB2; pETDuet-1 is used to express ACS (AAE) or PCT; pACYCDuet is used to express ilvC and ilvD; pETDuet is used to express bkd; and pRSFDuet-1 is used to express alsS and KAS IIIa. (See SEQ ID NOs: 1 to 9). Transformed cultures in BL21star(DE3) were induced with IPTG. In cases where the ACS or PCT pathway was used for 8M production, 1 g / L of isobutyric acid was fed to the culture. The fatty acids were extracted with ethyl acetate and methylated with 2.5% sulfuric acid in methanol. The methyl esters of the fatty acids were extracted with hexane and analyzed by GC / MS.
[0131] Product analysis
[0132] GC / MS was used to analyze the fatty acid composition after methylation. GC / MS analysis was performed on a Shimadzu GC-2010 system with a GCMS-QP2010S detector using a SHRXI-5MS column (0.25 μm thickness, 30 μm length, 0.25 mm diameter) and an injection temperature of 265°C. The injection mode was split, the oven temperature was 50°C, and the temperature gradient was as follows: 50°C from 0 to 4 minutes; 50°C to 100°C from 4 to 7.3 minutes with a gradient of 15°C; and 100°C to 260°C from 7.3 to 15.3 minutes with a gradient of 20°C. The identity and presence of the 8M compound in the fermentation product were confirmed by comparing its retention time and mass spectrum with that of an 8M standard purchased from Cayman Chemical (Ann Arbor, MI). They were identical.
[0133] Production of 8-methylnonanoic acid
[0134] like Figure 5 As shown, the culture system has a titer of about 1 mg / L. In order to produce 8M, a culture of a glycerol stock of an E. coli BL21 (DE3) strain overexpressing ACS or PCT, KASIIIa or KASIIIb and FatB or FatB2 was streaked onto an LB (AMP+Kan+Spect+) plate and incubated overnight at 37°C. A single colony was selected to inoculate 5 ml of LB (AMP+Kan+Spect+) liquid medium, and the culture was shaken at 250 rpm at 37°C overnight. 20 ml of LB (AMP+Kan+Spect+) liquid medium was inoculated with 2% of the overnight culture, and the culture was shaken at 250 rpm at 37°C until OD600 reached 0.6 (usually 3 hours). The culture was then cooled to 30°C, and 1 mM IPTG was added to induce protein expression. Three hours later, 1 g / L of isobutyric acid was added and sampled for 8M analysis.
[0135] To analyze 8M production, 0.5 ml of the culture was extracted with 0.5 ml of ethyl acetate for 30 minutes while shaking. After centrifugation at 14,000 rpm for 10 minutes, 100 μl of the ethyl acetate phase was transferred to a glass tube and dried under nitrogen. 1 ml of 2.5% sulfuric acid in methanol and the test tube were incubated in a 65°C water bath for 60 minutes. 2 ml of 0.9% NaCl and 2 ml of hexane were then added to extract the methyl esters of the fatty acids. After centrifugation at 2500 rpm for 10 minutes, the hexane phase was injected into a GC / MS for analysis of 8M concentration as described above.
[0136] Statement of Industrial Applicability / Technical Field
[0137] The present disclosure may be applied to the food, pharmaceutical and pharmacology industries.The present disclosure generally relates to a method for biosynthetically producing 8-methylnonanoic acid via a modified microbial strain.
[0138] Sequence of interest
[0139] Nucleic acid and amino acid sequences of FAT2B
[0140]
[0141] Nucleic acid sequences of thioesterases related to 8M synthesis
[0142]
[0143]
[0144]
[0145]
[0146]
[0147] Literature cited and incorporated by reference :
[0148] 1. Aluru M. et al., Differential expression of fatty acid synthase genes, Acl, Fat and Kas, in Capsicum fruit. J Exp Bot.; 54(388): 1655-64 (2003).
[0149] 2. Aza-Gonzalez C, et al. (2011). Molecular biology of capsaicinoid biosynthesis in chili pepper (Capsicum spp.). Plant Cell Rep. 30: 695-706.
[0150] 3. Belza A, Jessen AB. (2005), Bioactive food stimulants of sympathetic activity: effect on 24-henergy expenditure and fat oxidation. Eur J Clin Nutr., 59: 733–41.
[0151] 4. Bentley GJ et al., Engineering Escherichia coli to produce branched-chain fatty acids in high percentages, Metab Eng. 38: 148-58 (2016).
[0152] 5. Bosland and Baral, (2007), 'Bhut Jolokia'—The world's hottest known chile pepper is a putative naturally occurring interspecific hybrid, HortScience 42:222–24.
[0153] 6. Batchelor and Jones, (2000), Determination of the Scoville Heat Value for Hot Sauces and Chilies: An HPLC Experiment, J. Chem. Educ., 77(2) p 266.
[0154] 7. Catchpole et al., (2003), Extraction of chili, black pepper, and ginger with nearcritical CO2, propane, and dimethyl ether: analysis of the extracts by quantitative nuclear magnetic resonance, J. Agricultural and Food Chemistry 51:4853–60.
[0155] 8. Caterina MJ., et al., (1997), The capsaicin receptor: a heat-activated ion channel in the pain pathway, Nature 389, 816-24.
[0156] 9. Constant HL et al., (1996), Nonivamide, a constituent of Capsicum oleoresin, J. Natural Products, 59: 425–26.
[0157] 10. Crombie et al., 1955. Amides of vegetable origin. Part VI. Synthesis of capsaicin, J. Chem Soc., 1025-27.
[0158] 11. Curry, J. et al., (1999), Transcripts for possible capsaicinoid biosynthetic genes are different accumulated in pungent and non-pungent Capsicum spp., Plant Sci. 148: 47-57.
[0159] 12. Du J et al., (2011), Engineering microbialfactories for synthesis of value-added products, J Ind Microbiol Biotechnol. 38:873-90.
[0160] 13. Flagan SF, Utilization of capsaicin and vanillylamine as growth substrates by Capsicum (hot pepper)-associated bacteria, Env. Microbiology 8(3)560-65 (2006).
[0161] 14. Garces-Claver A. et al., (2007). Identification, validation and survey of a single nucleotide polymorphism (SNP) associated with pungency in Capsicum spp. Theor Appl Genet 115:907–16.
[0162] 15. Govindarajan and Sathyanarayana (1991), Capsicum–production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences, Critical Reviews in Food Science and Nutrition 29(6):435–74.
[0163] 16. Haushalter RW, et al., Production of anteiso-branched fatty acids in Escherichia coli; next generation biofuels with improved cold-flow properties, Metab. Eng. 26: 111–18 (2014).
[0164] 17. A. and Münch T., Microbial production of natural flavorings, ASM News, 63: 551-59 ( A, and Münch T., (1997), Microbial production of natural flavors, ASM News 63:551-59).
[0165] 18. Higashiguchi F., et al., (2006) Purification and structure determination of glucosides of capsaicin and dihydrocapsaicin from various Capsicum fruits, J Agric Food Chem. 54: 5948-5953.
[0166] 19. Howard T.P., et al., Synthesis of customized petroleum-replica fuel molecules by targeted modification of free fatty acid pools in Escherichia coli. Proc Natl Acad Sci USA 110:7636–41 (2013).
[0167] 20. Jiang W., et al., Enhanced production of branched-chain fatty acids by replacing β-ketoacyl-(acyl-carrier-protein) synthase III (FabH), Biotechnol Bioeng. 112: 1613-22 (2015).
[0168] 21. Jordt SE. and Julius D., (2002), Molecular basis for species-specific sensitivity to “hot” chili peppers. Cell. 108: 421–30.
[0169] 22. Kaminaga Y. et al., (2004) Molecular cloning and characterization of aglucosyltransferase catalyzing glucosylation of curcumin in cultured Catharanthus roseus cells. FEBS Lett. 567: 197-202.
[0170] 23. Kometani, T. et al., (1993) Glucosylation of capsaicin by cell suspension cultures of Coffea arabica. Biosci. Biotechnol. Biochem. 57, 2192–2193.
[0171] 24. Liang YT, et al., Capsaicinoids lower plasma cholesterol and improve endothelial function in hamsters, Eur J Nutr. 52:379-88 (2013).
[0172] 25. Lindsey K. and Yeoman M., The synthetic potential of immobilized cells of Capsicum frutescens mill cv. annuum. Planta 162:495-501 (1984).
[0173] 26. McMahon MD, and Prather KL, Functional screening and in vitro analysis reveal thioesterases with enhanced substrate specificity profiles that improve short-chain fatty acid production in Escherichia coli. Appl Environ Microbiol. 80: 1042-50 (2014).
[0174] 27. Mazourek, et al., (2009), A Dynamic Interface for Capsaicinoid Systems Biology, Plant Phys., 150: 1806-21.
[0175] 28. Ogawa K., et al., Evidence of capsaicin synthase activity of the Pun1-encoded protein and its role as a determinant of capsaicinoid accumulation in pepper, BMC Plant Biol. 15: 93 (2015).
[0176] 29. Prasad BC., (2006), Characterization of capsaicin synthase and identification of its gene (csyl) for pungency factor capsaicin in pepper (Capsicum sp.). Proc Natl Acad Sci US A. 103: 13315-20.
[0177] 30. Prasad BC. et al., (2008.), Characterization of capsaicin synthase and identification of its gene (csyl) for pungency factor capsaicin in pepper (Capsicum sp.). Proc Natl Acad Sci US A. 105: 20558.
[0178] 31. Qin C., et al., Whole-genome sequencing of cultivated and wild peppers provides insights into Capsicum domestication and specialization, Proc. Proc Natl Acad Sci USA. 111:5135-40 (2014).
[0179] 32. Reilly CA. et al., (2001), Determination of capsaicin, dihydrocapsaicin, and nonivamide in self-defense weapons by liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. J. Chromatogr A. 912: 259-67.
[0180] 33. Stewart C. et al., (2005) The Punl gene forpungency in pepper encodes a putative acyltransferase, Plant J. 42: 675-88.
[0181] 34. Stewart C. et al., (2007) Genetic control of pungency in C. chinense via the Punl locus. J Exp Bot. 58:979-91.
[0182] 35. Shimoda K., et al., (2007) Glycosylation of capsaicin and 8-nordihydrocapsaicin by cultured cells of Catharanthus roseus. Phytochemistry 68: 1391-96.
[0183] 36. Shockey JM. Et a., (2003), Arabidopsis contains a large superfamily of acyl-activating enzymes: phylogenetic and biochemical analysis reveals a new class of acyl-coenzyme A synthetases. Plant Physiol 132: 1065–76.
[0184] 37. Stewart C., et al., The Pun1 gene for pungency in pepper encodes a putative acyltransferase, Plant J. 42: 675-88 (2005).
[0185] 38. Suzuki T. et al., (1980) Intracellular localization of capsaicin and its analogs capsaicinoid in Capsicum fruit, microscopic investigation of the structure of the placenta of Capsicum annuum var annuum cv. Karayatsubusa. Plant Cell Physiol 21: 839–53.
[0186] 39. Suzuki T and Iwai K, (1984), Constituents of red pepper spices: chemistry, biochemistry, pharmacology and food science of the pungent principle of Capsicum species. In A Brossi, ed, THE ALKALOIDS: Chemistry and Pharmacology, Vol 23. Academic Press, Orlando, FL, pp 227–99.
[0187] 40. Tao H., et al., Metabolic engineering of microbes for branched-chain biodiesel production with low-temperature property, Biotechnol Biofuels. 8: 92 (2015).
[0188] 41. Thomas BV. et al., (1998), Simple method for quantitation of capsaicinoids in peppers using capillary gas chromatography. J Agric Food Chem., 46: 2655-63.
[0189] 42. Tominaga M. and Tominaga T., (2005), Structure and function of TRPV1, Pflugers Arch. Eur J Physiol.; 451: 143–50.
[0190] 43. Xu H., et al., Characterization of the formation of branched short-chain fatty acid: CoAs forbitter acid biosynthesis in hop glandular trichome, MOL., PLANT. 6: 1301-17 (2013).
[0191] 44. Walsh and Hoot, (2001), Phylogenetic relationships of Capsicum (Solanaceae) using DNA sequences from two noncoding regions: The chloroplastatpB-rbcL spacer region and nuclear waxy introns, Int. J. Plant Sci. 162: 1409–18.
[0192] 45. Weber N. et al., (2014), Biocatalytic potential of vanillin aminotransferase from Capsicum chinense. BMC Biotechnol. 14: 25.
[0193] 46. Yao et al., (1994), Supercritical carbon dioxide extraction of Scotch Bonnet (Capsicum annuum) and quantification of capsaicin and dihydrocapsaicin, J. Agr. Food Chem. 42: 1303–05.
[0194] Patents cited and incorporated by reference:
[0195] 1. Chen H. et al. (2015) Methods of using capsaicin synthase for the microbial production of capsaicinoids. PCT / US2015 / 011729.
[0196] 2. Chen et al., U.S. Patent 5,094,782.
[0197] 3. LaHann et al., U.S. Patent 4,493,848.
[0198] 4. Zhou R. and Yu X., 2014, Methods of making vanillin via the microbialfermentation of ferulic acid from eugenol using a plant dehydrogenase, PCT / US2014 / 063952.
Claims
1. A biosynthetic method for preparing capsaicin 8-methylnonanoic acid (8M), the biosynthetic method include: a) expressing KASIIIa, KASIIIb and thioesterase cloned from a plant of the genus Capsicum in a transformed cell system, wherein the transformed cell system is Escherichia coli, the thioesterase gene has a nucleic acid sequence of SEQ ID NO.5, the KasIIIa gene has a nucleic acid sequence of SEQ ID NO.6 and the KasIIIb gene has a nucleic acid sequence of SEQ ID NO.7; b) producing isobutyryl-CoA in said transformed cell system; and, c) Producing 8-methylnonanoic acid.
2. The biosynthetic method according to claim 1, wherein the cell system further comprises a glucose medium for the transformed cell system.
3. The biosynthetic method according to claim 1, wherein the thioesterase is FATB2.
4. The biosynthetic method according to any one of claims 1 to 3, wherein the Capsicum plant is Capsicum annuum.
5. The biosynthetic method according to any one of claims 1 to 3, wherein the cell system further comprises a pyruvate medium for the transformed cell system.
6. The biosynthetic method according to any one of claims 1 to 3, wherein the transformed cell system further comprises an acyl-CoA synthetase.
7. The biosynthetic method according to any one of claims 1 to 3, wherein the transformed cell system further comprises a propionate CoA transferase.
8. The biosynthetic method according to any one of claims 1 to 3, wherein the cell system is selected from the group consisting of an in vitro translation system and a combination thereof.
9. The biosynthetic method according to any one of claims 1 to 3, wherein the 8M is purified.
10. The biosynthetic method of claim 9, wherein the 8M is greater than 70% pure.
11. The biosynthetic method according to claim 10, wherein the 8M content is greater than 85% by weight based on dry weight.
12. The biosynthetic method according to any one of claims 1 to 3, wherein step c) include: i) purifying the crude product; and ii) removing the solvent under vacuum to provide a concentrated capsaicin product.
13. The biosynthetic method according to claim 12, wherein the crude product is purified by column chromatography.
14. The biosynthetic method according to claim 12, wherein the crude product is purified by acid-base extraction.
15. The biosynthetic method according to claim 12, wherein the crude product is purified by vacuum distillation.
16. The biosynthetic method according to claim 12, wherein the crude product is purified by semi-preparative HPLC.
17. A biosynthetic method for preparing medium-chain BCFA (branched-chain fatty acids), the biosynthetic method include: a) expressing KASIIIa, KASIIIb and thioesterase cloned from a plant of the genus Capsicum in a transformed cell system, wherein the transformed cell system is Escherichia coli, the thioesterase gene has a nucleic acid sequence of SEQ ID NO.5, the KasIIIa gene has a nucleic acid sequence of SEQ ID NO.6 and the KasIIIb gene has a nucleic acid sequence of SEQ ID NO.7; b) producing isobutyryl-CoA in said transformed cell system; and, c) Producing C8 to C14 branched chain fatty acids.
18. The biosynthetic method of claim 17, wherein the produced branched-chain fatty acids are used for biofuel production.
19. The biosynthetic method of claim 18, wherein the produced branched chain fatty acids are used for biofuel production and have enhanced cold flow properties.
20. The biosynthetic method of claim 17, further comprising using FabH and isobutyryl-CoA to generate a fatty acid synthase (FAS) system for the elongation of branched chain fatty acids.
21. The biosynthetic method according to claim 17, further comprising feeding α-ketoisovalerate or its sodium salt to the transformed cell system to express 8M.
22. The biosynthetic method of claim 21, further comprising expressing bkd in the transformed cell system.
23. The biosynthetic method according to claim 17, further comprising feeding isobutyric acid and / or a salt thereof to the transformed cell system to express 8M.
24. The biosynthetic method of claim 23, further comprising expressing CCL4 in the transformed cell system. The biosynthetic method according to claim 24 , wherein the CCL4 gene has a nucleic acid sequence of SEQ ID NO.
8.
26. The biosynthetic method according to claim 17, further comprising feeding isobutyric acid and / or a salt thereof to the transformed cell system to express 8M.
27. The biosynthetic method of claim 26, further comprising expressing PCT in the transformed cell system.
28. The biosynthetic method according to claim 27, wherein the PCT gene has a nucleic acid sequence of SEQ ID NO.
9.
29. The biosynthetic method according to claim 17, further comprising feeding isobutyric acid and / or a salt thereof to the transformed cell system to express 8M.
30. The biosynthetic method of claim 29, further comprising expressing alsS, ilvC, ilvD and bkd in the transformed cell system.
